BOVINE SERUM ALBUMIN MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Expanding biopharmaceutical industry

Global bovine serum albumin market growth is driven by the robust expansion of biopharmaceutical industry. Biologics have revolutionized the treatment of various chronic and life-threatening conditions with their high specificity and efficacy. The biologics segment accounts for a significant percentage of the global pharmaceutical sales. Many blockbusters biologic drugs are approaching patent expiration in the following years, which will intensify the worldwide biosimilars market. Both innovator biopharmaceutical firms and their biosimilar counterparts require reliable supply chains for critical raw materials in large commercial quantities.

With rising healthcare expenditures, there has been policy level focus on enhancing access to affordable biologics especially in developing regions. The establishment of required manufacturing infrastructure to facilitate ‘Make in India’ and ‘Make in China’ projects can boost demand for bovine serum albumin from these countries. Life science clusters have emerged as strategic priorities receiving government funding and tax incentives to attract biopharma investments. Many leading global biotech giants have established or expanded their presence in Asia, Latin America and Central & Eastern Europe in order to capitalize on opportunities across emerging biosimilar, vaccine and generic injectable segments.The biopharmaceutical industry is rapidly scaling up capacities to support its diverse and robust pipeline of biologic drugs and vaccines.